Search clinical trials for: 0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient

Total 5 results

DR. MALA KHAN
Bangladesh Reference Institute of Chemical Measurements (BRICM)

Completed

Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx (COVID-19)

Efficacy, Self | Effect of Drug | Virus Infection, RNA

Bangladesh
Weill Medical College of Cornell University
Boehringer Ingelheim

Completed

COVID-19 Respiratory Outcomes Registry

Covid19

United States
Theodor Bilharz Research Institute

Completed

Effect of Dexmedetomidine on Improving Intubating Conditions Without the Use of Muscle Relaxant

Intubation | Dexmedetomidine | Muscle Relaxation

Egypt
Memorial Sloan Kettering Cancer Center
Genentech, Inc.; Weill Medical College of Cornell University

Completed

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Gastric Cancer | Esophageal Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Neuroblastoma

United States

3

Subscribe